The management of cutaneous disease in lupus erythematosus is challeng
ing. Limited data have been published and mainly consists of individua
l case reports, retrospective case series, and open trials involving s
mall numbers of patients. The currently available treatment options ar
e discussed in this article. Emphasis is placed on optimal use of anti
malarial drugs and the risk to benefit ratio of other therapeutic agen
ts.